Pediatric Renal Masses – Diagnosis and Management

🩺 Introduction

Pediatric renal masses represent a diverse group of congenital, benign, and malignant conditions. The most common cause is Wilms’ tumor (nephroblastoma), but other important differential diagnoses include mesoblastic nephroma, clear cell sarcoma, rhabdoid tumor, renal cell carcinoma, and multicystic dysplastic kidney.

Early identification and accurate differentiation are crucial for appropriate management and improving survival outcomes.

🔬 Differential Diagnosis of Pediatric Renal Masses

Category	Common Examples	Key Features
Malignant	Wilms’ tumor (≈85%) Clear cell sarcoma of the kidney (CCSK) Rhabdoid tumor of kidney (RTK) Renal cell carcinoma (RCC, rare)	Rapidly enlarging flank mass, hematuria, hypertension, constitutional symptoms
Benign	Congenital mesoblastic nephroma (infants) Multilocular cystic nephroma Angiomyolipoma (in tuberous sclerosis)	Often asymptomatic, discovered incidentally
Non-neoplastic mimics	Hydronephrosis Polycystic kidney disease Renal abscess or hematoma	Variable imaging findings; clinical correlation essential

🔍 Clinical Presentation

• Painless abdominal/flank mass (most common presenting feature)
• Hematuria (microscopic or gross)
• Hypertension (due to renin secretion or compression of renal vessels)
• Fever, anorexia, weight loss (in malignant cases)
• Varicocele (left-sided, non-compressible in upright position → suggests renal vein involvement)

🧪 Diagnostic Approach

1. Initial Evaluation

History and Physical Examination:

Duration, pain, hematuria, associated syndromes (e.g., Beckwith–Wiedemann, WAGR).

Laboratory Tests:

• CBC, renal function tests
• Urinalysis (hematuria, infection)
• Liver function tests, LDH (tumor burden markers)

2. Imaging Studies

Ultrasound (USG):

• First-line modality; differentiates cystic vs solid lesion.
• Assesses bilateral involvement and relation to vessels.

Contrast-enhanced CT or MRI abdomen:

• Defines extent, contralateral kidney, vascular invasion, lymph nodes, metastases.

Chest CT/X-ray:

• Detects pulmonary metastases (especially in Wilms’ tumor).

Doppler ultrasound:

• Evaluates renal vein and inferior vena cava involvement.

3. Histopathological Diagnosis

• Wilms’ tumor: Triphasic pattern (blastemal, epithelial, stromal)
• CCSK: Cells with clear cytoplasm, aggressive course
• Rhabdoid tumor: Eosinophilic cytoplasmic inclusions, poor prognosis
• Biopsy is generally avoided in suspected Wilms’ tumor unless diagnosis is uncertain or lesion is atypical (per SIOP protocol).

🧠 Staging (Wilms’ Tumor – NWTS/COG System)

Stage	Description
I	Confined to kidney, completely resected
II	Extends beyond kidney but completely excised
III	Residual non-hematogenous tumor confined to abdomen
IV	Hematogenous metastases (lung, liver, bone, brain)
V	Bilateral renal involvement

⚕️ Management Principles

🔹 1. Wilms’ Tumor (Nephroblastoma)

• Surgery: Radical nephrectomy with lymph node sampling.
• Chemotherapy: Vincristine + Actinomycin D ± Doxorubicin depending on stage and histology.
• Radiotherapy: Indicated in advanced stages (III–IV) or unfavorable histology.
• Bilateral disease: Nephron-sparing surgery after pre-operative chemotherapy.

🔹 2. Congenital Mesoblastic Nephroma

• Most common renal tumor in infants <1 year.
• Treatment: Complete nephrectomy; chemotherapy rarely required.
• Prognosis: Excellent.

🔹 3. Clear Cell Sarcoma

• High metastatic potential (bone, brain).
• Treatment: Nephrectomy + multi-agent chemotherapy + radiotherapy.
• Prognosis: Intermediate (5-year survival ≈70%).

🔹 4. Rhabdoid Tumor of Kidney

• Highly aggressive, often with brain involvement.
• Treatment: Surgery + intensive chemotherapy + radiotherapy.
• Prognosis: Poor (<30% 3-year survival).

🔹 5. Renal Cell Carcinoma (RCC)

• Rare in children (>10 years).
• Treatment: Radical nephrectomy ± targeted therapy (for metastasis).

🔬 Follow-Up

• Periodic ultrasound/CT scans for recurrence or contralateral disease.
• Monitor renal function, growth, and blood pressure post-treatment.
• Long-term surveillance for chemotherapy-related toxicity (anthracyclines → cardiotoxicity).

📈 Prognosis

• Overall survival for Wilms’ tumor exceeds 90% with multimodal therapy.
• Adverse factors: unfavorable histology, advanced stage, age >2 years, tumor rupture.

---

📚 Key High-Yield Points

1. Wilms’ tumor = most common pediatric renal malignancy.
2. USG = best initial imaging modality.
3. Avoid biopsy in classical Wilms’ presentation.
4. Vincristine + Actinomycin D = standard chemotherapy backbone.
5. Rhabdoid tumor → worst prognosis; mesoblastic nephroma → best prognosis.

---

🔗 Test Your Skill

Challenge your understanding of pediatric renal masses with a practice quiz designed for high-stakes exams.

Start MCQ Quiz Now